ES2160977T3 - 1-fenilalquil-1,2,3,6-tetrahidropiridinas para el tratamiento de la enfermedad de alzheimer. - Google Patents

1-fenilalquil-1,2,3,6-tetrahidropiridinas para el tratamiento de la enfermedad de alzheimer.

Info

Publication number
ES2160977T3
ES2160977T3 ES97951323T ES97951323T ES2160977T3 ES 2160977 T3 ES2160977 T3 ES 2160977T3 ES 97951323 T ES97951323 T ES 97951323T ES 97951323 T ES97951323 T ES 97951323T ES 2160977 T3 ES2160977 T3 ES 2160977T3
Authority
ES
Spain
Prior art keywords
sub
rent
alcoxyl
mono
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97951323T
Other languages
English (en)
Inventor
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Application granted granted Critical
Publication of ES2160977T3 publication Critical patent/ES2160977T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I) EN LA QUE Y REPRESENTA -CH- O -N-; R 1 REPRESENTA HIDROGENO, UN HALOGENO, UN GRUPO CF 3 , (C 1 - C 4 )ALQUILO O (C 1 - C 4 )ALCOXILO; R 2 REPRESENTA UN GRUPO MET ILO O ETILO, R 3 Y R 4 REPRESENTAN CADA UNO HIDROGENO O UN (C 1 - C 3 )ALQUILO; X REPRESENTA (A) UN (C SUB,1 - C 6 )ALQUILO;, (C 1 - C 6 )ALCOXILO, UN (C SUB,3 - C 7 )CARBOXIALQUILO; O UN (C 1 C 4 )ALCOXICARBONIL(C 1 - C 6 )ALCOXILO; (B) UN RADICAL ELEGIDO ENTRE UN (C 3 - C 7 )CICLOALQUILO, (C 3 - C SUB,7 )CICLOALQUICOXI, (C 3 C 7 )CICLOALQUILMETILO, (C S UB,3 C 7 )CICLOALQUILAMINO Y CICLOHEXENILO, PUDIENDO DICHO RADICAL SUSTITUIRSE POR UN HALOGENO, HIDROXI, (C 1 C SUB,4)ALCOXI, CARBOXI, (C 1 - C 4 ALCOXICARBONILO, AMINO, MONO- O DI - (C 1 C 4 )ALQUILAMINO; O UN (C) UN GRUPO ELEGIDO ENTRE UN FENILO, FENOXI, FENILAMINO, N - (C 1 C 3 )ALQUILFENILAMINO, FENILMETILO, FENILETILO, FENILCARBO NILO, FENILTIO, FENILSULFONILO, FENILSULFINILO O ESTIRILO, PUDIENDO DICHO GRUPO SER MONO- O POLISUSTIRUIDO EN EL GRUPO FENILO POR UN HALOGENO, CF 3 , (C 1 C 4 ALQUILO, (C SUB,1 - C 4 )ALCOXI, CIANO, AMINO, MONO- O DI-(C 1 - C SUB,4 )ALQUILAMINO, (C 1 C 4 )ACILAMINO, CARBOXI, (C SUB,1 C 4 )ALCOXICARBONILO, AMINOCARBONILO, MONO- O DI (C 1 - C 4 )ALQUILAMINOCARBONILO, AMINO(C 1 C SUB,4 )ALQUILO, HIDROXI(C 1 - C 4 )ALQUILO O HALOGENO(C S 1 ) - C 4 ) ALQUILO ASI COMO A UN PROCEDIMIENTO PARA SU PREPARACION Y LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. ESTOS COMPUESTOS TIENEN UNA ACTIVIDAD NEUROTROFICA Y NEUROPROTECTORA.
ES97951323T 1996-12-13 1997-12-12 1-fenilalquil-1,2,3,6-tetrahidropiridinas para el tratamiento de la enfermedad de alzheimer. Expired - Lifetime ES2160977T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615335A FR2757160B1 (fr) 1996-12-13 1996-12-13 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Publications (1)

Publication Number Publication Date
ES2160977T3 true ES2160977T3 (es) 2001-11-16

Family

ID=9498641

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97951323T Expired - Lifetime ES2160977T3 (es) 1996-12-13 1997-12-12 1-fenilalquil-1,2,3,6-tetrahidropiridinas para el tratamiento de la enfermedad de alzheimer.

Country Status (32)

Country Link
US (1) US6034090A (es)
EP (1) EP0950048B1 (es)
JP (1) JP3881384B2 (es)
KR (1) KR100560358B1 (es)
CN (1) CN1129579C (es)
AT (1) ATE202561T1 (es)
AU (1) AU730143B2 (es)
BR (1) BR9713916A (es)
CA (1) CA2275353C (es)
CY (1) CY2274B1 (es)
CZ (1) CZ289789B6 (es)
DE (1) DE69705429T2 (es)
DK (1) DK0950048T3 (es)
EE (1) EE03763B1 (es)
ES (1) ES2160977T3 (es)
FR (1) FR2757160B1 (es)
GR (1) GR3036643T3 (es)
HK (1) HK1023997A1 (es)
HU (1) HU224347B1 (es)
IL (1) IL130003A (es)
IS (1) IS1969B (es)
NO (1) NO312720B1 (es)
NZ (1) NZ336033A (es)
PL (1) PL190789B1 (es)
PT (1) PT950048E (es)
RS (1) RS49807B (es)
RU (1) RU2189975C2 (es)
SI (1) SI0950048T1 (es)
SK (1) SK283331B6 (es)
TR (1) TR199901291T2 (es)
UA (1) UA52707C2 (es)
WO (1) WO1998025903A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
FR2832405B1 (fr) * 2001-11-19 2004-12-10 Sanofi Synthelabo Tetrahydropyridyl-alkyl-heterocycles azotes, procede pour leur preparation et compositions pharmaceutiques les contenant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
IE34545B1 (en) * 1969-10-01 1975-06-11 Continental Pharma Amino-alcohols,their salts and process for preparing the same
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds

Also Published As

Publication number Publication date
JP3881384B2 (ja) 2007-02-14
BR9713916A (pt) 2000-02-29
DE69705429D1 (de) 2001-08-02
PT950048E (pt) 2001-12-28
NO992869L (no) 1999-06-11
AU730143B2 (en) 2001-03-01
DK0950048T3 (da) 2001-09-24
NO992869D0 (no) 1999-06-11
HU224347B1 (hu) 2005-08-29
TR199901291T2 (xx) 1999-10-21
IL130003A (en) 2004-09-27
HUP0001185A3 (en) 2002-10-28
CZ211399A3 (cs) 2000-09-13
KR100560358B1 (ko) 2006-03-14
IL130003A0 (en) 2000-02-29
SK283331B6 (sk) 2003-06-03
CA2275353C (en) 2007-05-22
CY2274B1 (en) 2003-07-04
CN1129579C (zh) 2003-12-03
EE9900237A (et) 1999-12-15
HUP0001185A2 (hu) 2000-10-28
CZ289789B6 (cs) 2002-04-17
WO1998025903A1 (fr) 1998-06-18
RU2189975C2 (ru) 2002-09-27
JP2001505902A (ja) 2001-05-08
US6034090A (en) 2000-03-07
YU24399A (sh) 2001-07-10
FR2757160A1 (fr) 1998-06-19
CA2275353A1 (en) 1998-06-18
IS1969B (is) 2004-12-15
NZ336033A (en) 2000-12-22
EP0950048A1 (fr) 1999-10-20
CN1240427A (zh) 2000-01-05
KR20000069422A (ko) 2000-11-25
EE03763B1 (et) 2002-06-17
UA52707C2 (uk) 2003-01-15
RS49807B (sr) 2008-08-07
GR3036643T3 (en) 2001-12-31
NO312720B1 (no) 2002-06-24
PL190789B1 (pl) 2006-01-31
AU5489398A (en) 1998-07-03
SK78699A3 (en) 2000-01-18
IS5075A (is) 1999-06-10
FR2757160B1 (fr) 1999-03-12
DE69705429T2 (de) 2002-05-16
PL334071A1 (en) 2000-01-31
ATE202561T1 (de) 2001-07-15
SI0950048T1 (en) 2001-10-31
EP0950048B1 (fr) 2001-06-27
HK1023997A1 (en) 2000-09-29

Similar Documents

Publication Publication Date Title
GT199900067A (es) Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica.
ES2155134T3 (es) Derivados de imidazolidina y su utilizacion.
ES2162942T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
DK1155019T3 (da) Substituerede porphyriner og deres terapeutiske anvendelse
ES2161231T3 (es) Compuestos heterociclicos como antagonistas de bradiquinina.
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
ATE238307T1 (de) Substituierte porphyrinen
DK1263752T3 (da) LPA-receptoragonister og -antagonister og fremgangsmåde til anvendelse heraf
ES2030777T3 (es) Un metodo para preparar un derivado de n-indanil-carboxamida, y fungicida agricola/horticola que contiene el derivado como ingrediente activo.
GT199700079A (es) Derivados triciclos sustituidos con fenilamino
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
EA199900462A1 (ru) Способы и композиции для стимуляции роста невритов, использующие соединения с афинностью к fkbp12 в комбинации с нейротрофическими факторами
CU23241B7 (es) 2-fenil-1-(4(2-aminoetoxi)-benzil)-indol en combinacion con estrogenos
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
DK0950057T3 (da) 3-pyridylenantiomerer og deres anvendelse som analgetika
GT199800106A (es) Azetidinas.
BR0315437A (pt) Composição para o tratamento dos cabelos, usos da mesma e método para o tratamento dos cabelos
DE69935670D1 (de) Behandlung von dyskinesie durch mu-selektive opioidantagonisten
ES2157524T3 (es) Diselenuros y selenosulfuros utilizables como agentes antioxidantes.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
BRPI0408846A (pt) compostos para o tratamento de infecções por flaviviridae
ES2160977T3 (es) 1-fenilalquil-1,2,3,6-tetrahidropiridinas para el tratamiento de la enfermedad de alzheimer.
ES2189956T3 (es) Derivados de quinolina, procedimientos para su preparacion y su uso como medicamentos.
BRPI0415434A (pt) compostos e métodos para tratar e prevenir arritmias cardìacas induzidas por exercìcios

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 950048

Country of ref document: ES